Dr. Klein on Precision Medicine for Prostate Cancer

Eric Klein, MD
Published Online: Wednesday, Jul 12, 2017



Eric Klein, MD, professor of Surgery, Lerner College of Medicine, Cleveland Clinic, discusses precision medicine in patients with prostate cancer.

The prostate cancer field has entered the precision medicine era, explains Klein. There are now clinically significant tools in all the different spaces in prostate cancer, such as better screening and tests for the tumor.
 


Eric Klein, MD, professor of Surgery, Lerner College of Medicine, Cleveland Clinic, discusses precision medicine in patients with prostate cancer.

The prostate cancer field has entered the precision medicine era, explains Klein. There are now clinically significant tools in all the different spaces in prostate cancer, such as better screening and tests for the tumor.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x